Who Should Avoid GLP-1 Medications GLP-1 treatments are generally not recommended for: Individuals with certain thyroid conditions Those with a history of specific endocrine disorders People who are pregnant or planning a pregnancy Anyone advised against it by a healthcare provider This is why eligibility screening is essential before starting treatment
The mobile phase used was ultrapure helium, and its flow rate was maintained at 1.0 mL/min, with an in-built filter for oxygen and humidity
M1 microglia promote the production and release of pro-inflammatory cytokines, exacerbating nerve damage, while M2 microglia promote the release of repairing and phagocytic neurotrophic factors to maintain immune system balance
Lustig RH , Sudol M, Pfaff DW, Federoff HJ
Journal of the American Chemical Society, 141, 1421014219
GLP-1, a crucial peptide produced in the small intestine, plays a significant role in weight management